Search bioRxivSearch

bioRxiv · 10.1101/813915

The polyvertex score (PVS): a whole-brain phenotypic prediction framework for neuroimaging studies

Abstract

The traditional brain mapping approach has greatly advanced our understanding of the localized effect of the brain on behavior. However, the statistically significant brain regions identified by standard mass univariate models only explain minimal variance in behavior despite increased sample sizes and statistical power. This is potentially due to the generalizable explanatory signal in the brain being non-sparse, therefore not captured by the thresholded, localized model. Here we introduced the Bayesian polyvertex score (PVS-B), a whole-brain prediction framework that aggregates the effect sizes across all vertices to predict individual variability in behavior. The PVS-B estimates the posterior mean effect size at each vertex with mass univariate summary statistics and the correlation structure of the imaging phenotype, and weights the imaging phenotype of participants from an independent sample with these posterior mean effect sizes to estimate the generalizable effect of a brain-behavior association. Empirical data showed that the PVS-B was able to double the variance explained in general cognitive ability by an n-back fMRI contrast when compared to prediction models based on the mass univariate parameter estimates as well as models in which only vertices thresholded based on p-value were included. A fivefold improvement in variance explained by the PVS-B was observed using a stop signal task fMRI contrast to predict individual variability in the stop signal reaction time. We believe that the PVS-B can shed light on the multivariate investigation of brain-behavioral associations and will empower small scale neuroimaging studies with more reliable and accurate effect size estimates.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Zhao, W., Palmer, C. E., Thompson, W. K., Jernigan, T. L., Dale, A. M., Fan, C. C.. 2019-10-22. The polyvertex score (PVS): a whole-brain phenotypic prediction framework for neuroimaging studies. https://doi.org/10.1101/813915

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience